In conclusion, circRNA HECTD1 expression correlates with increased disease risk, disease severity, elevated inflammation, and recurrence risk of AIS, which discloses the potential of circRNA HECTD1 as a biomarker for AIS. This evidence concerns the gene HECTD1 and androgen insensitivity syndrome.